SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061137
Filing Date
2023-11-08
Accepted
2023-11-08 16:15:35
Documents
69
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rani-20230930.htm   iXBRL 10-Q 2668614
2 EX-10.1 rani-ex10_1.htm EX-10.1 423390
3 EX-31.1 rani-ex31_1.htm EX-31.1 18372
4 EX-31.2 rani-ex31_2.htm EX-31.2 18409
5 EX-32.1 rani-ex32_1.htm EX-32.1 11316
6 GRAPHIC img175231464_0.jpg GRAPHIC 31740
7 GRAPHIC img175231464_1.jpg GRAPHIC 19529
  Complete submission text file 0000950170-23-061137.txt   10275756

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rani-20230930_pre.xml EX-101.PRE 477392
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rani-20230930_lab.xml EX-101.LAB 594817
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rani-20230930.xsd EX-101.SCH 70761
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rani-20230930_cal.xml EX-101.CAL 42135
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rani-20230930_def.xml EX-101.DEF 362538
63 EXTRACTED XBRL INSTANCE DOCUMENT rani-20230930_htm.xml XML 1634433
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40672 | Film No.: 231388076
SIC: 2834 Pharmaceutical Preparations